A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Clinical trial NCT06072196 · COMPLETED

Trial details

NCT number: NCT06072196
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Prostatic Neoplasms

Start date: 2023-10-04
Primary completion: 2024-12-18
Enrollment: 3017

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.